Literature DB >> 24464181

IL-15 receptor alpha rs2228059 A>C polymorphism was associated with a decreased risk of esophageal cancer in a Chinese population.

Jun Yin1, Liming Wang, Yijun Shi, Aizhong Shao, Weifeng Tang, Xu Wang, Wenbo Zhang, Guowen Ding, Chao Liu, Yijang Chen, Suocheng Chen, Haiyong Gu.   

Abstract

Esophageal cancer is the sixth leading cause of cancer-related deaths worldwide. Esophageal cancer is very aggressive; genetic polymorphisms may explain in part the individual differences in esophageal cancer susceptibility. We conducted a hospital based case-control study to evaluate the genetic effects of functional single nucleotide polymorphisms (SNPs) in the interleukin (IL)-15 and IL-15 receptor alpha (IL-15RA) gene on the development of esophageal cancer. A total of 380 esophageal squamous cell carcinoma (ESCC) cases and 380 controls were recruited for this study. The genotypes were determined using a custom-by-design 48-Plex SNPscan(TM) kit. The IL-15RA rs2228059 A>C polymorphism was associated with a decreased risk of ESCC in a recessive genetic model; However, there was no significant association between the other five SNPs and ESCC risk. Stratified analyses indicated a significantly decreased risk of ESCC associated with the IL-15RA rs2228059 A>C polymorphism was evident among male, older, non-smoker, and non-drinker patients. These findings indicated that the functional polymorphism, IL-15RA rs2228059 A>C, might contribute to ESCC susceptibility. However, the statistical power of our study was limited because of the moderate sample size and absence of a validation cohort. Large well-designed studies are warranted to confirm our findings.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24464181     DOI: 10.1007/s11033-014-3042-8

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  24 in total

1.  Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DPI gene in the 13q34 amplicon.

Authors:  T Shinomiya; T Mori; Y Ariyama; T Sakabe; Y Fukuda; Y Murakami; Y Nakamura; J Inazawa
Journal:  Genes Chromosomes Cancer       Date:  1999-04       Impact factor: 5.006

2.  Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.

Authors:  Michele A Kutzler; Tara M Robinson; Michael A Chattergoon; Daniel K Choo; Andrew Y Choo; Philip Y Choe; Mathura P Ramanathan; Rose Parkinson; Sagar Kudchodkar; Yutaka Tamura; Maninder Sidhu; Vidia Roopchand; J Joseph Kim; George N Pavlakis; Barbara K Felber; Thomas A Waldmann; Jean D Boyer; David B Weiner
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

Review 3.  Cytokine control of memory T-cell development and survival.

Authors:  Kimberly S Schluns; Leo Lefrançois
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

4.  Juxtacrine function of interleukin-15/interleukin-15 receptor system in tumour derived human B-cell lines.

Authors:  K Tsukamoto; Y C Huang; W C Dorsey; B Carns; V Sharma
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

5.  Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses.

Authors:  Steven E Riechman; G Balasekaran; Stephen M Roth; Robert E Ferrell
Journal:  J Appl Physiol (1985)       Date:  2004-12

6.  Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia.

Authors:  Jun J Yang; Cheng Cheng; Wenjian Yang; Deqing Pei; Xueyuan Cao; Yiping Fan; Stanley B Pounds; Geoffrey Neale; Lisa R Treviño; Deborah French; Dario Campana; James R Downing; William E Evans; Ching-Hon Pui; Meenakshi Devidas; W P Bowman; Bruce M Camitta; Cheryl L Willman; Stella M Davies; Michael J Borowitz; William L Carroll; Stephen P Hunger; Mary V Relling
Journal:  JAMA       Date:  2009-01-28       Impact factor: 56.272

7.  The role of interleukin-15 polymorphisms in adult acute lymphoblastic leukemia.

Authors:  Dandan Lin; Chunliang Liu; Mengxing Xue; Rengyun Liu; Lan Jiang; Xiao Yu; Guangming Bao; Fang Deng; Mingjie Yu; Jiafu Ao; Yifeng Zhou; Depei Wu; Haiyan Liu
Journal:  PLoS One       Date:  2010-10-25       Impact factor: 3.240

8.  Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

Authors:  K H Grabstein; J Eisenman; K Shanebeck; C Rauch; S Srinivasan; V Fung; C Beers; J Richardson; M A Schoenborn; M Ahdieh
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

Review 9.  Twelve immunotherapy drugs that could cure cancers.

Authors:  Martin A Cheever
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

10.  Cytokine and cytokine receptor single-nucleotide polymorphisms predict risk for non-small cell lung cancer among women.

Authors:  Alison L Van Dyke; Michele L Cote; Angie S Wenzlaff; Wei Chen; Judith Abrams; Susan Land; Craig N Giroux; Ann G Schwartz
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06       Impact factor: 4.254

View more
  1 in total

1.  Interleukin 15 receptor alpha rs2228059 A > C polymorphism decreased risk of gastric cardiac adenocarcinoma in a Chinese population.

Authors:  Jun Yin; Chao Liu; Xu Wang; Liming Wang; Yijun Shi; Weifeng Tang; Guowen Ding; Ruiping Liu; Suocheng Chen; Haiyong Gu; Liang Zheng
Journal:  Tumour Biol       Date:  2014-04-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.